336 related articles for article (PubMed ID: 16417859)
1. Efficacy and safety of topiramate in refractory epilepsy of childhood: long-term follow-up study.
Grosso S; Franzoni E; Iannetti P; Incorpora G; Cardinali C; Toldo I; Verrotti A; Caterina Moscano F; Lo Faro V; Mazzone L; Zamponi N; Boniver C; Spalice A; Parisi P; Morgese G; Balestri P
J Child Neurol; 2005 Nov; 20(11):893-7. PubMed ID: 16417859
[TBL] [Abstract][Full Text] [Related]
2. Topiramate: efficacy and tolerability in children according to epilepsy syndromes.
Mikaeloff Y; de Saint-Martin A; Mancini J; Peudenier S; Pedespan JM; Vallée L; Motte J; Bourgeois M; Arzimanoglou A; Dulac O; Chiron C
Epilepsy Res; 2003 Mar; 53(3):225-32. PubMed ID: 12694931
[TBL] [Abstract][Full Text] [Related]
3. The efficacy and side effects of topiramate on refractory epilepsy in infants and young children: a multi-center clinical trial.
Al Ajlouni S; Shorman A; Daoud AS
Seizure; 2005 Oct; 14(7):459-63. PubMed ID: 16087357
[TBL] [Abstract][Full Text] [Related]
4. Topiramate as add-on drug in children, adolescents and young adults with Lennox-Gastaut syndrome: an Italian multicentric study.
Coppola G; Caliendo G; Veggiotti P; Romeo A; Tortorella G; De Marco P; Pascotto A
Epilepsy Res; 2002 Sep; 51(1-2):147-53. PubMed ID: 12350390
[TBL] [Abstract][Full Text] [Related]
5. Clinical experience with open-label topiramate use in infants younger than 2 years of age.
Watemberg N; Goldberg-Stern H; Ben-Zeev B; Berger I; Straussberg R; Kivity S; Kramer U; Brand N; Lerman-Sagie T
J Child Neurol; 2003 Apr; 18(4):258-62. PubMed ID: 12760428
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of topiramate in infants according to epilepsy syndromes.
Grosso S; Galimberti D; Farnetani MA; Cioni M; Mostardini R; Vivarelli R; Di Bartolo RM; Bernardoni E; Berardi R; Morgese G; Balestri P
Seizure; 2005 Apr; 14(3):183-9. PubMed ID: 15797353
[TBL] [Abstract][Full Text] [Related]
7. Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
Bootsma HP; Coolen F; Aldenkamp AP; Arends J; Diepman L; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M
Epilepsy Behav; 2004 Jun; 5(3):380-7. PubMed ID: 15145308
[TBL] [Abstract][Full Text] [Related]
8. Topiramate for drug-resistant epilepsies.
Yeung S; Ferrie CD; Murdoch-Eaton DG; Livingston JH
Eur J Paediatr Neurol; 2000; 4(1):31-3. PubMed ID: 10701102
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of topiramate in children younger than 2 years old.
Valencia I; Fons C; Kothare SV; Khurana DS; Yum S; Hardison HH; Legido A
J Child Neurol; 2005 Aug; 20(8):667-9. PubMed ID: 16225812
[TBL] [Abstract][Full Text] [Related]
10. Topiramate slow dose titration: improved efficacy and tolerability.
Albsoul-Younes AM; Salem HA; Ajlouni SF; Al-Safi SA
Pediatr Neurol; 2004 Nov; 31(5):349-52. PubMed ID: 15519117
[TBL] [Abstract][Full Text] [Related]
11. Topiramate as an add-on antiepileptic drug in treating refractory canine idiopathic epilepsy.
Kiviranta AM; Laitinen-Vapaavuori O; Hielm-Björkman A; Jokinen T
J Small Anim Pract; 2013 Oct; 54(10):512-20. PubMed ID: 24032479
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of topiramate in childhood and adolescent epilepsy: a clinical experience.
Mohamed K; Appleton R; Rosenbloom L
Seizure; 2000 Mar; 9(2):137-41. PubMed ID: 10845739
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of levetiracetam in infants and young children with refractory epilepsy.
Grosso S; Cordelli DM; Franzoni E; Coppola G; Capovilla G; Zamponi N; Verrotti A; Morgese G; Balestri P
Seizure; 2007 Jun; 16(4):345-50. PubMed ID: 17368928
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Safety, Tolerability, and Efficacy of Cannabidiol in Children with Refractory Epilepsy: Results from an Expanded Access Program in the US.
Sands TT; Rahdari S; Oldham MS; Caminha Nunes E; Tilton N; Cilio MR
CNS Drugs; 2019 Jan; 33(1):47-60. PubMed ID: 30460546
[TBL] [Abstract][Full Text] [Related]
15. Topiramate as add-on drug in severe myoclonic epilepsy in infancy: an Italian multicenter open trial.
Coppola G; Capovilla G; Montagnini A; Romeo A; Spanò M; Tortorella G; Veggiotti P; Viri M; Pascotto A
Epilepsy Res; 2002 Mar; 49(1):45-8. PubMed ID: 11948006
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of topiramate in refractory epilepsy: a long-term prospective trial.
Tartara A; Sartori I; Manni R; Galimberti CA; Di Fazio M; Perucca E
Ital J Neurol Sci; 1996 Dec; 17(6):429-32. PubMed ID: 8978450
[TBL] [Abstract][Full Text] [Related]
17. Topiramate monotherapy as broad-spectrum antiepileptic drug in a naturalistic clinical setting.
Guerrini R; Carpay J; Groselj J; van Oene J; Schreiner A; Lahaye M; Schwalen S;
Seizure; 2005 Sep; 14(6):371-80. PubMed ID: 15961326
[TBL] [Abstract][Full Text] [Related]
18. Long-term assessment of topiramate for epilepsy: an open-label, single-arm, multicentre, prospective study in a naturalistic setting.
Hufnagel A; Kowalik A; Rettig K; Schreiner A; Schäuble B;
Clin Drug Investig; 2011 Nov; 31(11):779-90. PubMed ID: 21967069
[TBL] [Abstract][Full Text] [Related]
19. Topiramate: a review of its use in childhood epilepsy.
Ormrod D; McClellan K
Paediatr Drugs; 2001; 3(4):293-319. PubMed ID: 11354701
[TBL] [Abstract][Full Text] [Related]
20. Use of topiramate in childhood generalized seizure disorders.
Wheless JW
J Child Neurol; 2000; 15 Suppl 1():S7-13. PubMed ID: 11218056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
